Assessing for unique immunomodulatory and neuroplastic profiles of physical activity subtypes: A focus on psychiatric disorders

Brain, Behavior, and Immunity

Volumn 39, Issue , 2014, Pages 42-55

  Eyre, Harris A ^a,b   Baune, Bernhard T ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

Alzheimer's disease; Cognitive dysfunction; Depression; Exercise; Immune; Mild cognitive impairment; Neuroplasticity; Physical activity; Psychiatry; Subtypes

Indexed keywords

CYTOKINE; NEUROTROPHIN; NERVE GROWTH FACTOR;

AEROBIC EXERCISE; AGE RELATED COGNITIVE DECLINE; COGNITIVE DEFECT; COMPARATIVE STUDY; DISEASE SEVERITY; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; MAJOR DEPRESSION; NERVE CELL PLASTICITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RELAXATION TRAINING; RESISTANCE TRAINING; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE; ADOLESCENT; ADULT; AGED; COGNITION DISORDERS; DEPRESSIVE DISORDER; FEMALE; IMMUNOLOGY; KINESIOTHERAPY; MALE; METABOLISM; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; CYTOKINES; DEPRESSIVE DISORDER; EXERCISE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; NEURONAL PLASTICITY; YOUNG ADULT;

EID: 84902317689     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.10.026     Document Type: Review

References (119)

1. Baker L.D., Bayer-Carter J.L., Skinner J., Montine T.J., Cholerton B.A., Callaghan M., Leverenz J.B., Walter B.K., Tsai E., Postupna N., Lampe J., Craft S. High-intensity physical activity modulates diet effects on cerebrospinal amyloid-beta levels in normal aging and mild cognitive impairment. J. Alzheimers Dis. 2012, 28:137-146.
2. Balsamo S., Willardson J.M., Frederico Sde S., Prestes J., Balsamo D.C., Dahan da C.N., Dos Santos-Neto L., Nobrega O.T. Effectiveness of exercise on cognitive impairment and Alzheimer's disease. Int. J. Gen. Med. 2013, 6:387-391.
3. Baune B., Eyre H. Novel perspectives on the role of immune biomarkers in exercise and depression. Brain Behav. Immun. 2012, 26:512.
4. Baune B.T., Smith E., Reppermund S., Air T., Samaras K., Lux O., Brodaty H., Sachdev P., Trollor J.N. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney memory and aging study. Psychoneuroendocrinology 2012, 37:1521-1530.
5. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., Beattie M.S., Malenka R.C. Control of synaptic strength by glial TNFalpha. Science 2002, 295:2282-2285.
6. Beavers K.M., Brinkley T.E., Nicklas B.J. Effect of exercise training on chronic inflammation. Clin. Chim. Acta 2010, 411:785-793.
7. Bohlmeijer E., Prenger R., Taal E., Cuijpers P. The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: a meta-analysis. J. Psychosom. Res. 2010, 68:539-544.
8. Bowman A.J., Clayton R.H., Murray A., Reed J.W., Subhan M.M., Ford G.A. Effects of aerobic exercise training and yoga on the baroreflex in healthy elderly persons. Eur. J. Clin. Invest. 1997, 27:443-449.
9. Bridle C., Spanjers K., Patel S., Atherton N.M., Lamb S.E. Effect of exercise on depression severity in older people: systematic review and meta-analysis of randomised controlled trials. Br. J. Psychiatry 2012, 201:180-185.
10. Brown B.M., Peiffer J.J., Martins R.N. Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease?. Mol. Psychiatry 2012, 18:864-874.
11. Butterfield D.A., Reed T., Newman S.F., Sultana R. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic. Biol. Med. 2007, 43:658-677.
12. Carlson L.E., Speca M., Patel K.D., Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom. Med. 2003, 65:571-581.
13. Carlson L.E., Speca M., Faris P., Patel K.D. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav. Immun. 2007, 21:1038-1049.
14. Cassilhas R.C., Viana V.A., Grassmann V., Santos R.T., Santos R.F., Tufik S., Mello M.T. The impact of resistance exercise on the cognitive function of the elderly. Med. Sci. Sports Exerc. 2007, 39:1401-1407.
15. Cassilhas R.C., Lee K.S., Fernandes J., Oliveira M.G., Tufik S., Meeusen R., de Mello M.T. Spatial memory is improved by aerobic and resistance exercise through divergent molecular mechanisms. Neuroscience 2012, 202:309-317.
16. Chi I., Jordan-Marsh M., Guo M., Xie B., Bai Z. Tai chi and reduction of depressive symptoms for older adults: a meta-analysis of randomized trials. Geriatr. Gerontol. Int. 2013, 13:3-12.
17. Cohen C.A., Shea A.A., Heffron C.L., Schmelz E.M., Roberts P.C. Intra-abdominal fat depots represent distinct immunomodulatory microenvironments: a murine model. PLoS One 2013, 8:e66477.
18. Cooney G.M., Dwan K., Greig C.A., Lawlor D.A., Rimer J., Waugh F.R., McMurdo M., Mead G.E. Exercise for depression. Cochrane Database Syst. Rev. 2013, 9. (CD004366).
19. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
20. Davis J.C., Bryan S., Marra C.A., Sharma D., Chan A., Beattie B.L., Graf P., Liu-Ambrose T. An economic evaluation of resistance training and aerobic training versus balance and toning exercises in older adults with mild cognitive impairment. PLoS One 2013, 8:e63031.
21. Dik M.G., Jonker C., Hack C.E., Smit J.H., Comijs H.C., Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005, 64:1371-1377.
22. Donges C.E., Duffield R., Drinkwater E.J. Effects of resistance or aerobic exercise training on interleukin-6, C-reactive protein, and body composition. Med. Sci. Sports Exerc. 2010, 42:304-313.
23. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
24. Eikelenboom P., Hoozemans J.J., Veerhuis R., van Exel E., Rozemuller A.J., van Gool W.A. Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease. Alzheimer's Res. Ther. 2012, 4:15.
25. Eller T., Vasar V., Shlik J., Maron E. Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:445-450.
26. Engelhart M.J., Geerlings M.I., Meijer J., Kiliaan A., Ruitenberg A., van Swieten J.C., Stijnen T., Hofman A., Witteman J.C., Breteler M.M. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch. Neurol. 2004, 61:668-672.
27. Erickson K.I., Voss M.W., Prakash R.S., Basak C., Szabo A., Chaddock L., Kim J.S., Heo S., Alves H., White S.M., Wojcicki T.R., Mailey E., Vieira V.J., Martin S.A., Pence B.D., Woods J.A., McAuley E., Kramer A.F. Exercise training increases size of hippocampus and improves memory. Proc. Natl. Acad. Sci. USA 2011, 108:3017-3022.
28. Erickson K.I., Gildengers A.G., Butters M.A. Physical activity and brain plasticity in late adulthood. Dialogues Clin. Neurosci. 2013, 15:99-108.
29. Eyre H., Baune B.T. Neuroimmunomodulation in unipolar depression: a focus on chronobiology and chronotherapeutics. J. Neural Transm. 2012, 119:1147-1166.
30. Eyre H., Baune B.T. Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012, 37:1397-1416.
31. Eyre H.A., Papps E., Baune B.T. Treating depression and depression-like behavior with physical activity: an immune perspective. Front. Psychiatry/Front. Res. Found. 2013, 4:3.
32. Fang C.Y., Reibel D.K., Longacre M.L., Rosenzweig S., Campbell D.E., Douglas S.D. Enhanced psychosocial well-being following participation in a mindfulness-based stress reduction program is associated with increased natural killer cell activity. J. Altern. Complement. Med. 2010, 16:531-538.
33. Froeliger B., Garland E.L., McClernon F.J. Yoga meditation practitioners exhibit greater gray matter volume and fewer reported cognitive failures: results of a preliminary voxel-based morphometric analysis. Evid. Based Complement. Altern. Med. 2012, 2012:821307.
34. Funk J.A., Gohlke J., Kraft A.D., McPherson C.A., Collins J.B., Jean Harry G. Voluntary exercise protects hippocampal neurons from trimethyltin injury: possible role of interleukin-6 to modulate tumor necrosis factor receptor-mediated neurotoxicity. Brain Behav. Immun. 2011, 25:1063-1077.
35. Gallegos A.M., Hoerger M., Talbot N.L., Krasner M.S., Knight J.M., Moynihan J.A., Duberstein P.R. Toward identifying the effects of the specific components of mindfulness-based stress reduction on biologic and emotional outcomes among older adults. J. Altern. Complement. Med. 2013, 19:787-792.
36. Gavillet M., Allaman I., Magistretti P.J. Modulation of astrocytic metabolic phenotype by proinflammatory cytokines. Glia 2008, 56:975-989.
37. Goldin P., Ziv M., Jazaieri H., Gross J.J. Randomized controlled trial of mindfulness-based stress reduction versus aerobic exercise: effects on the self-referential brain network in social anxiety disorder. Front. Hum. Neurosci. 2012, 6:295.
38. Goldin P., Ziv M., Jazaieri H., Hahn K., Gross J.J. MBSR vs aerobic exercise in social anxiety: fMRI of emotion regulation of negative self-beliefs. Soc. Cogn. Affect. Neurosci. 2013, 8:65-72.
39. Grossman P., Niemann L., Schmidt S., Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J. Psychosom. Res. 2004, 57:35-43.
40. Guillemin G.J., Brew B.J., Noonan C.E., Takikawa O., Cullen K.M. Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. Neuropathol. Appl. Neurobiol. 2005, 31:395-404.
41. Hannestad J., Dellagioia N., Gallezot J.D., Lim K., Nabulsi N., Esterlis I., Pittman B., Lee J.Y., O'Connor K.C., Pelletier D., Carson R.E. The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [C]PBR28 PET study. Brain Behav. Immun. 2013, 33:131-138.
42. Hayes S.M., Hayes J.P., Cadden M., Verfaellie M. A review of cardiorespiratory fitness-related neuroplasticity in the aging brain. Front. Aging Neurosci. 2013, 5:31.
43. Hiles S.A., Baker A.L., de Malmanche T., Attia J. A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity. Brain Behav. Immun. 2012, 26:1180-1188.
44. Hofer S., Eisenbach C., Lukic I.K., Schneider L., Bode K., Brueckmann M., Mautner S., Wente M.N., Encke J., Werner J., Dalpke A.H., Stremmel W., Nawroth P.P., Martin E., Krammer P.H., Bierhaus A., Weigand M.A. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit. Care Med. 2008, 36:404-408.
45. Hofmann S.G., Sawyer A.T., Witt A.A., Oh D. The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. J. Consult. Clin. Psychol. 2010, 78:169-183.
46. Hotting K., Roder B. Beneficial effects of physical exercise on neuroplasticity and cognition. Neurosci. Biobehav. Rev 2013, [Epub ahead of print]. 10.1016/j.neubiorev.2013.04.005.
47. Irwin M.R., Olmstead R. Mitigating cellular inflammation in older adults: a randomized controlled trial of tai chi chih. Am. J. Geriatr. Psychiatry 2012, 20:764-772.
48. Kawanishi N., Yano H., Yokogawa Y., Suzuki K. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc. Immunol. Rev. 2010, 16:105-118.
49. Kohut M.L., McCann D.A., Russell D.W., Konopka D.N., Cunnick J.E., Franke W.D., Castillo M.C., Reighard A.E., Vanderah E. Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults. Brain Behav. Immun. 2006, 20:201-209.
50. Koyama A., O'Brien J., Weuve J., Blacker D., Metti A.L., Yaffe K. The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. J. Gerontol. A Biol. Sci. Med. Sci. 2013, 68:433-440.
51. Kramer A.F., Hahn S., Cohen N.J., Banich M.T., McAuley E., Harrison C.R., Chason J., Vakil E., Bardell L., Boileau R.A., Colcombe A. Ageing, fitness and neurocognitive function. Nature 1999, 400:418-419.
52. Kreisl W.C., Lyoo C.H., McGwier M., Snow J., Jenko K.J., Kimura N., Corona W., Morse C.L., Zoghbi S.S., Pike V.W., McMahon F.J., Turner R.S., Innis R.B., Biomarkers Consortium P.E.T.R.P.T. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. Brain 2013, 136:2228-2238.
53. Krogh J., Saltin B., Gluud C., Nordentoft M. The DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of strength versus aerobic versus relaxation training for patients with mild to moderate depression. J. Clin. Psychiatry 2009, 70:790-800.
54. Krogh J., Nordentoft M., Sterne J.A., Lawlor D.A. The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials. J. Clin. Psychiatry 2011, 72:529-538.
55. Krogh J., Videbech P., Thomsen C., Gluud C., Nordentoft M. DEMO-II trial. Aerobic exercise versus stretching exercise in patients with major depression-a randomised clinical trial. PLoS One 2012, 7:e48316.
56. Krstic D., Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat. Rev. Neurol. 2013, 9:25-34.
57. Lavretsky H., Alstein L.L., Olmstead R.E., Ercoli L.M., Riparetti-Brown M., Cyr N.S., Irwin M.R. Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial. Am. J. Geriatr. Psychiatry 2011, 19:839-850.
58. Leonard B., Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav. Rev. 2012, 36:764-785.
59. Leung R., Proitsi P., Simmons A., Lunnon K., Guntert A., Kronenberg D., Pritchard M., Tsolaki M., Mecocci P., Kloszewska I., Vellas B., Soininen H., Wahlund L.O., Lovestone S. Inflammatory proteins in plasma are associated with severity of Alzheimer's disease. PLoS One 2013, 8:e64971.
60. Li J., Ramenaden E.R., Peng J., Koito H., Volpe J.J., Rosenberg P.A. Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J. Neurosci. 2008, 28:5321-5330.
61. Lin F., Friedman E., Quinn J., Chen D.-G., Mapstone M. Effect of leisure activities on inflammation and cognitive function in an aging sample. Arch. Gerontol. Geriat. 2012, 54(3):e398-e404.
62. Liu-Ambrose T., Nagamatsu L.S., Graf P., Beattie B.L., Ashe M.C., Handy T.C. Resistance training and executive functions: a 12-month randomized controlled trial. Arch. Intern. Med. 2010, 170:170-178.
63. Liu-Ambrose T., Nagamatsu L.S., Voss M.W., Khan K.M., Handy T.C. Resistance training and functional plasticity of the aging brain: a 12-month randomized controlled trial. Neurobiol. Aging 2012, 33:1690-1698.
64. Luders E., Kurth F., Toga A.W., Narr K.L., Gaser C. Meditation effects within the hippocampal complex revealed by voxel-based morphometry and cytoarchitectonic probabilistic mapping. Front. Psychol. 2013, 4:398.
65. Lujan H.L., DiCarlo S.E. Physical activity, by enhancing parasympathetic tone and activating the cholinergic anti-inflammatory pathway, is a therapeutic strategy to restrain chronic inflammation and prevent many chronic diseases. Med. Hypotheses 2013, 80:548-552.
66. Ma X.M., Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell. Biol. 2009, 10:307-318.
67. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 2009, 33:355-366.
68. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
69. Mills N.T., Scott J.G., Wray N.R., Cohen-Woods S., Baune B.T. The role of cytokines in depression in adolescents: a systematic review. J. Child Psychol. Psychiatry 2013, 54:816-835.
70. Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6:e1000097.
71. Moller A.B., Vendelbo M.H., Rahbek S.K., Clasen B.F., Schjerling P., Vissing K., Jessen N. Resistance exercise, but not endurance exercise, induces IKKbeta phosphorylation in human skeletal muscle of training-accustomed individuals. Pflugers Arch. 2013, 465:1785-1795.
72. Moylan S., Maes M., Wray N.R., Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatry 2012, 18:595-606.
73. Nagamatsu L.S., Handy T.C., Hsu C.L., Voss M., Liu-Ambrose T. Resistance training promotes cognitive and functional brain plasticity in seniors with probable mild cognitive impairment. Arch. Intern. Med. 2012, 172:666-668.
74. Nagamatsu L.S., Chan A., Davis J.C., Beattie B.L., Graf P., Voss M.W., Sharma D., Liu-Ambrose T. Physical activity improves verbal and spatial memory in older adults with probable mild cognitive impairment: a 6-month randomized controlled trial. J. Aging Res. 2013, 2013:861893.
75. Nilsson K., Gustafson L., Hultberg B. C-reactive protein level is decreased in patients with Alzheimer's disease and related to cognitive function and survival time. Clin. Biochem. 2011, 44:1205-1208.
76. Oh B., Butow P., Mullan B., Clarke S., Beale P., Pavlakis N., Lee M., Rosenthal D., Larkey L., Vardy J. Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Support. Care Cancer 2012, 20:1235-1242.
77. Oh B., Choi S.M., Inamori A., Rosenthal D., Yeung A. Effects of qigong on depression: a systemic review. Evid. Based Complement. Altern. Med. 2013, 2013:134737.
78. Park S.E., Dantzer R., Kelley K.W., McCusker R.H. Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. J. Neuroinflamm. 2011, 8:12.
79. Paul N.A., Stanton S.J., Greeson J.M., Smoski M.J., Wang L. Psychological and neural mechanisms of trait mindfulness in reducing depression vulnerability. Soc. Cogn. Affect. Neurosci. 2013, 8:56-64.
80. Pavlov V.A., Parrish W.R., Rosas-Ballina M., Ochani M., Puerta M., Ochani K., Chavan S., Al-Abed Y., Tracey K.J. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav. Immun. 2009, 23:41-45.
81. Pedersen M., Pedersen K.K., Bruunsgaard H., Krabbe K.S., Thomsen C., Færch K., Pedersen B.K., Mortensen E.L. Cognitive functions in middle aged individuals are related to metabolic disturbances and aerobic capacity: a cross-sectional study. PLoS One 2012, 7.
82. Penninx B.W., Rejeski W.J., Pandya J., Miller M.E., Di Bari M., Applegate W.B., Pahor M. Exercise and depressive symptoms: a comparison of aerobic and resistance exercise effects on emotional and physical function in older persons with high and low depressive symptomatology. J. Gerontol. B Psychol. Sci. Soc. Sci. 2002, 57:P124-P132.
83. Pereira D.S., de Queiroz B.Z., Miranda A.S., Rocha N.P., Felicio D.C., Mateo E.C., Favero M., Coelho F.M., Jesus-Moraleida F., Gomes Pereira D.A., Teixeira A.L., Maximo Pereira L.S. Effects of physical exercise on plasma levels of brain-derived neurotrophic factor and depressive symptoms in elderly women-a randomized clinical trial. Arch. Phys. Med. Rehabil. 2013, 94:1443-1450.
84. Pickering M., Cumiskey D., O'Connor J.J. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp. Physiol. 2005, 90:663-670.
85. Pitkala K.H., Poysti M.M., Laakkonen M.L., Tilvis R.S., Savikko N., Kautiainen H., Strandberg T.E. Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial. JAMA Int. Med. 2013, 173:894-901.
86. Rahman A., Ting K., Cullen K.M., Braidy N., Brew B.J., Guillemin G.J. The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. PLoS One 2009, 4:e6344.
87. Ravindran A.V., da Silva T.L. Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: a systematic review. J. Affect. Disord. 2013, 150:707-719.
88. Reale M., Iarlori C., Gambi F., Feliciani C., Salone A., Toma L., DeLuca G., Salvatore M., Conti P., Gambi D. Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. J. Neuroimmunol. 2004, 148:162-171.
89. Rethorst C.D., Trivedi M.H. Evidence-based recommendations for the prescription of exercise for major depressive disorder. J. Psychiatr. Pract. 2013, 19:204-212.
90. Rethorst C.D., Moynihan J., Lyness J.M., Heffner K.L., Chapman B.P. Moderating effects of moderate-intensity physical activity in the relationship between depressive symptoms and interleukin-6 in primary care patients. Psychosom. Med. 2011, 73:265-269.
91. Rethorst C.D., Toups M.S., Greer T.L., Nakonezny P.A., Carmody T.J., Grannemann B.D., Huebinger R.M., Barber R.C., Trivedi M.H. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol. Psychiatry 2012, 18:1119-1124.
92. Rimer J., Dwan K., Lawlor D.A., Greig C.A., McMurdo M., Morley W., Mead G.E. Exercise for depression. Cochrane Database Syst. Rev. 2012, 7. (CD004366).
93. Rizzo A.M., Corsetto P.A., Montorfano G., Opizzi A., Faliva M., Giacosa A., Ricevuti G., Pelucchi C., Berra B., Rondanelli M. Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters. Nutr. J. 2012, 11:82.
94. Rohleder N., Miller G.E. Acute deviations from long-term trait depressive symptoms predict systemic inflammatory activity. Brain Behav. Immun. 2008, 22:709-716.
95. Roig M., Nordbrandt S., Geertsen S.S., Nielsen J.B. The effects of cardiovascular exercise on human memory: a review with meta-analysis. Neurosci. Biobehav. Rev. 2013, 37:1645-1666.
96. Roque F.R., Hernanz R., Salaices M., Briones A.M. Exercise training and cardiometabolic diseases: focus on the vascular system. Curr. Hypertens. Rep. 2013, 15:204-214.
97. Ruscheweyh R., Willemer C., Kruger K., Duning T., Warnecke T., Sommer J., Volker K., Ho H.V., Mooren F., Knecht S., Floel A. Physical activity and memory functions: an interventional study. Neurobiol. Aging 2011, 32:1304-1319.
98. Salminen A., Ojala J., Kaarniranta K., Haapasalo A., Hiltunen M., Soininen H. Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype. Eur. J. Neurosci. 2011, 34:3-11.
99. Schmidt R., Schmidt H., Curb J.D., Masaki K., White L.R., Launer L.J. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Ann. Neurol. 2002, 52:168-174.
100. Schuch F.B., de Almeida Fleck M.P. Is exercise an efficacious treatment for depression? A comment upon recent negative findings. Front. Psychiatry/Front. Res. Found. 2013, 4:20.
101. Starkie R., Ostrowski S.R., Jauffred S., Febbraio M., Pedersen B.K. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J. 2003, 17:884-886.
102. Steele M.L., Robinson S.R. Reactive astrocytes give neurons less support: implications for Alzheimer's disease. Neurobiol. Aging 2012, 33(423):e413-e421.
103. Sundelof J., Kilander L., Helmersson J., Larsson A., Ronnemaa E., Degerman-Gunnarsson M., Basun H., Lannfelt L., Basu S. Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study. J. Alzheimers Dis. 2009, 18:79-87.
104. Swardfager W., Lanctot K., Rothenburg L., Wong A., Cappell J., Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biol. Psychiatry 2010, 68:930-941.
105. Swardfager W., Herrmann N., Marzolini S., Saleem M., Shammi P., Oh P.I., Albert P.R., Daigle M., Kiss A., LanctÔt K.L. Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease. Brain Behav. Immun. 2011, 25:1264-1271.
106. Tang Y.Y., Lu Q., Fan M., Yang Y., Posner M.I. Mechanisms of white matter changes induced by meditation. Proc. Natl. Acad. Sci. USA 2012, 109:10570-10574.
107. Tanzi R.E., Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005, 120:545-555.
108. Taylor W.D., Aizenstein H.J., Alexopoulos G.S. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol. Psychiatry 2013, 18:963-974.
109. Tilleux S., Hermans E. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J. Neurosci. Res. 2007, 85:2059-2070.
110. Trivedi M.H., Greer T.L., Church T.S., Carmody T.J., Grannemann B.D., Galper D.I., Dunn A.L., Earnest C.P., Sunderajan P., Henley S.S., Blair S.N. Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. J. Clin. Psychiatry 2011, 72:677-684.
111. van Himbergen T.M., Beiser A.S., Ai M., Seshadri S., Otokozawa S., Au R., Thongtang N., Wolf P.A., Schaefer E.J. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham heart study. Arch. Neurol. 2012, 69:594-600.
112. Voelcker-Rehage C., Niemann C. Structural and functional brain changes related to different types of physical activity across the life span. Neurosci. Biobehav. Rev 2013, [Epub ahead of print]. 10.1016/j.neubiorev.2013.01.028.
113. Voelcker-Rehage C., Godde B., Staudinger U.M. Cardiovascular and coordination training differentially improve cognitive performance and neural processing in older adults. Front. Hum. Neurosci. 2011, 5:26.
114. Vogelzangs N., Duivis H.E., Beekman A.T., Kluft C., Neuteboom J., Hoogendijk W., Smit J.H., de Jonge P., Penninx B.W. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl. Psychiatry 2012, 2:e79.
115. Wang C.W., Chan C.L., Ho R.T., Tsang H.W., Chan C.H., Ng S.M. The effect of qigong on depressive and anxiety symptoms: a systematic review and meta-analysis of randomized controlled trials. Evid. Based Complement. Altern. Med. 2013, 2013:716094.
116. Wei G.X., Xu T., Fan F.M., Dong H.M., Jiang L.L., Li H.J., Yang Z., Luo J., Zuo X.N. Can taichi reshape the brain? A brain morphometry study. PLoS One 2013, 8:e61038.
117. Wyss-Coray T., Rogers J. Inflammation in Alzheimer disease - a brief review of the basic science and clinical literature. Cold Spring Harb. Perspect. Med. 2012, 2:a006346.
118. Yaffe K., Kanaya A., Lindquist K., Simonsick E.M., Harris T., Shorr R.I., Tylavsky F.A., Newman A.B. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004, 292:2237-2242.
119. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 2011, 25:181-213.